Supernus Announces Record Full Year 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Supernus Pharma (SUPN) Tops Q4 EPS by 21c
February 26, 2019 4:59 PM ESTSupernus Pharma (NASDAQ: SUPN) reported Q4 EPS of $0.48, $0.21 better than the analyst estimate of $0.27. Revenue for the quarter came in at $115.9 million versus the consensus estimate of $105.47 million.
Guidance:
Net product sales in the range of $435 million to $455 million.... More